Tania H Watts Selected Research

4-1BB Ligand (4 1BB Ligand)

8/2011	Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
1/2009	Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
4/2002	Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tania H Watts Research Topics

Disease

18	Infections 01/2022 - 04/2002
13	Human Influenza (Influenza) 01/2021 - 04/2002
6	Neoplasms (Cancer) 01/2021 - 01/2005
6	Virus Diseases (Viral Diseases) 12/2018 - 06/2008
5	Persistent Infection 01/2018 - 12/2007
3	Rheumatoid Arthritis 01/2022 - 01/2017
2	Lymphoma (Lymphomas) 01/2021 - 03/2002
2	Lymphocytic Choriomeningitis 12/2018 - 01/2018
2	Inflammation (Inflammations) 12/2018 - 01/2017
2	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2017
1	COVID-19 01/2022
1	Ankylosing Spondylitis 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Chylous Ascites 05/2019
1	Wasting Syndrome (Wasting Disease) 05/2019
1	Confusion (Bewilderment) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	HIV Infections (HIV Infection) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017
1	Splenomegaly 11/2014
1	Berylliosis 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2005
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2005
1	Communicable Diseases (Infectious Diseases) 01/2005
1	Myocarditis (Carditis) 12/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2003

Drug/Important Bio-Agent (IBA)

7	TNF Receptor-Associated Factor 1IBA 01/2021 - 06/2008
5	AntigensIBA 01/2019 - 07/2003
5	AntibodiesIBA 11/2018 - 05/2006
4	Peptides (Polypeptides)IBA 01/2021 - 03/2002
4	LigandsIBA 12/2018 - 09/2013
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017 - 06/2010
3	CytokinesIBA 01/2022 - 11/2005
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
3	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2018 - 01/2009
3	4-1BB Ligand (4 1BB Ligand)IBA 08/2011 - 04/2002
2	Immunoglobulin G (IgG)IBA 01/2015 - 05/2006
2	Type II Tumor Necrosis Factor ReceptorsIBA 09/2013 - 01/2013
2	EpitopesIBA 01/2013 - 11/2005
2	VaccinesIBA 08/2011 - 01/2011
1	mRNA VaccinesIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	InterferonsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Protein Kinase CIBA 01/2021
1	Chemokine ReceptorsIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Glucocorticoid-Induced TNFR-Related ProteinIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2019
1	MethylcholanthreneIBA 05/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 05/2019
1	Viral AntigensIBA 12/2018
1	Insulin ReceptorIBA 12/2018
1	Fc Receptors (Fc Receptor)IBA 11/2018
1	5' Untranslated Regions (5' UTR)IBA 01/2018
1	LipopolysaccharidesIBA 01/2017
1	CD30 LigandIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Interferon Type IIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2015
1	Alanine Transaminase (SGPT)IBA 11/2014
1	Viral VaccinesIBA 09/2013
1	Interleukin-7 (Interleukin 7)IBA 01/2012
1	Adenovirus VaccinesIBA 08/2011
1	NucleoproteinsIBA 08/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Inactivated VaccinesIBA 01/2011
1	LectinsIBA 01/2011
1	BerylliumIBA 09/2008
1	Programmed Cell Death 1 ReceptorIBA 12/2007
1	Antiviral Agents (Antivirals)IBA 11/2005
1	Amino Acids FDA Link 08/2005
1	DNA (Deoxyribonucleic Acid)IBA 09/2003
1	AutoantibodiesIBA 09/2003
1	Histocompatibility Antigens Class IIIBA 03/2002

Therapy/Procedure

4	Immunotherapy 11/2015 - 06/2010
3	Therapeutics 11/2018 - 06/2010
1	Transplantation 01/2005